Real-world testing of serum lactate dehydrogenase among patients with metastatic colorectal cancer in the United States
Abnormal baseline LDH levels were associated with shorter OS; however, only one-fifth of patients receiving chemotherapy underwent LDH testing. Efforts to increase LDH testing could be valuable in helping guide treatment decisions.
Authors
- Helene Ostojic (ORCID: https://orcid.org/0000-0002-0448-9195)
- Nasreen Khan (ORCID: https://orcid.org/0000-0001-6184-0503)
- Zdravko P. Vassilev (ORCID: https://orcid.org/0000-0002-4902-6784)
- Heinz‐Josef Lenz (ORCID: https://orcid.org/0000-0003-2178-9568)
- Emmanuelle Dochy
- Orsolya Lunacsek (ORCID: https://orcid.org/0000-0003-4872-9813)
- Xiaoyun Pan (ORCID: https://orcid.org/0000-0003-2844-4044)
Institutions
- University of Southern California (US)
- Bayer (United States) (US)
- USC Norris Comprehensive Cancer Center (US)
- Bayer (Switzerland) (CH)
- Bayer (Germany) (DE)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-06-28
- DOI
- https://doi.org/10.1093/oncolo/oyaf192
- Citations
- 3
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.14